{"news_desk": "Business", "print_page": "3", "section_name": "Health", "subsection_name": null, "byline": {"original": "By ANDREW POLLACK", "person": [{"rank": 1, "role": "reported", "firstname": "Andrew", "organization": "", "lastname": "POLLACK"}]}, "abstract": "Researchers report Mapp Biopharmaceutical drug ZMapp apparently prevents death from Ebola in its first rigorous clinical trial; say results, however, are inconclusive.", "type_of_material": "News", "word_count": "519", "lead_paragraph": "ZMapp, a potential treatment for Ebola, seemed to prevent death in its first rigorous trial, but researchers said the results were not conclusive.", "pub_date": "2016-02-24T00:00:00Z", "document_type": "article", "slideshow_credits": null, "headline": {"main": "Ebola Drug Shows Signs of Efficacy in Small Clinical Trial", "print_headline": "Ebola Drug Shows Signs of Efficacy in Small Trial"}, "snippet": "ZMapp, a potential treatment for Ebola, seemed to prevent death in its first rigorous trial, but researchers said the results were not conclusive.", "multimedia": [], "web_url": "http://www.nytimes.com/2016/02/24/science/ebola-drug-shows-signs-of-efficacy-in-small-clinical-trial.html", "keywords": [{"rank": "1", "is_major": "Y", "value": "Ebola Virus", "name": "subject"}, {"rank": "2", "is_major": "Y", "value": "ZMapp (Drug)", "name": "subject"}, {"rank": "3", "is_major": "Y", "value": "Mapp Biopharmaceutical Inc", "name": "organizations"}, {"rank": "4", "is_major": "N", "value": "Drugs (Pharmaceuticals)", "name": "subject"}, {"rank": "5", "is_major": "N", "value": "Africa", "name": "glocations"}], "blog": [], "_id": "56cd33aa38f0d838c6ea4c14", "source": "The New York Times"}